Category: General Cardiology

Aortic regurgitation is more likely to occur in subpulmonic ventricular septal defect (VSD) than perimembranous VSD.

Beta blockers in heart failure: Earlier beta blockers were contraindicated in heart failure. But now they are known to reduce long term mortality.

Vernakalant hydrochloride is a novel anti arrhythmic agent which is atrial selective, blocking the early activating potassium channel and frequency dependent sodium channel.

Statins reduce progression of atherosclerotic AS. Study suggests statins may have a role in reducing the progression of rheumatic mitral valve disease also.

2009 Canadian Cardiovascular Society guidelines has recognized high sensitivity C-reactive protein (hs-CRP) as a major cardiovascular risk factor.

Sleep apnea and cardiovascular disease: sleep apnea can cause hypertension, bradyarrhythmias, AF, pulmonary hypertension and precipitate nocturnal angina.

Management of primary pulmonary hypertension: latest addition to the therapeutic armamentarium are oral endothelin antagonists bosentan and ambrisentan.

Aliskiren an antihypertensive: inhibits renin, the first limb of the RAAS, seems to have a potential in preventing the progression of CKD.

Aspirin for primary prevention of cardiovascular events is not well established and needs to weigh risk benefit ratio in each case.

Several changes occur after birth during the transition from the fetal circulation.